Clinical Trials
2
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
No trials found
News
Advancements in Ocular Therapies: Updates on Dry Eye, AMD, and Myopia Management
ā¢ Aldeyra Therapeutics resubmitted its NDA for reproxalap, targeting dry eye disease symptoms with both acute and chronic activity demonstrated in trials. ā¢ Aviceda Therapeutics completed enrollment for its Phase 2b SIGLEC study, evaluating AVD-104 for geographic atrophy secondary to age-related macular degeneration. ā¢ Ocular Therapeutix accelerates the SOL-1 Phase 3 trial of Axpaxli for wet AMD, expecting topline data in Q4 2025.